pandemic and seasonal H1N1 influenza vaccine (Antagen Biosciences)

N/A

Report date: 2025/03/19 11:45:02

Base Information

Drug Namepandemic and seasonal H1N1 influenza vaccine (Antagen Biosciences)

Drug Alias Namerecombinant protein based influenza vaccine (Antagen Biosciences)universal influenza vaccine (Antagen Biosciences)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAntagen Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesAntagen Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A